N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide

Request For Quotation
N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: Nanjing Shizhou Biology Technology Co.,Ltd  
Tel: 025-85560043 15850508050
Email: cindy.huang@synzest.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Tel: 13370042665 18916960931
Email: 2596183085@qq.com

N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide manufacturers

  • STAT3-IN-B9
  • STAT3-IN-B9 pictures
  • $70.00
  • 2026-08-08
  • CAS:825611-06-1
  • Purity: 98.19%
  • Supply Ability: 10g
N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide Basic information
Product Name:N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide
Synonyms:N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide;STAT3 IN B9;STAT3INB9;STAT3-IN-B9;STAT3INB9,STAT-3-IN-B9;STAT3-IN-4;STAT3-IN-B9, 10 mM in DMSO
CAS:825611-06-1
MF:C20H13NO5S
MW:379.38592
EINECS:
Product Categories:
Mol File:825611-06-1.mol
N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide Structure
N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide Chemical Properties
Safety Information
MSDS Information
N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide Usage And Synthesis
DescriptionSTAT3-IN-B9 inhibits the proliferation of tumor cells harboring abnormal activation of STAT3, such as, MDA-MB-468, MDA-MB-231 and DU145.
UsesSTAT3-IN-4 (compound B9) is a STAT3 inhibitor with Kd values for STAT3 (I634S/Q635G) and WT are 22.75 and 4.59 μM, respectively. STAT3-IN-4 can inhibit the proliferation of tumor cells[1].
References[1] Huang M, et al. Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5172-5176. DOI:10.1016/j.bmcl.2016.09.073
N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide Preparation Products And Raw materials
Tag:N-(4-hydroxyphenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide(825611-06-1) Related Product Information
2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-(2,2-dimethyl-1-propoxypropyl)-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)- GYY 4137 Morpholine salt gamma-Glu-Cys trifluoroacetate salt Astaxanthin Glycodeoxycholic acid S3I-201